An Experimental Analytical and In Vitro Approach to Bridge Between Different Heated Tobacco Product Variants

1 Institute of Medicine Committee to Assess the Science Base for Tobacco Harm Reduction: Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction; edited by K. Stratton, P. Shetty, R. Wallace, and S. Bondurant, National Academy Press, Washington, DC, USA, 2001. Institute of Medicine Committee to Assess the Science Base for Tobacco Harm Reduction Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction edited by StrattonK. ShettyP. WallaceR. BondurantS. National Academy Press Washington, DC, USA 2001 Search in Google Scholar

2 Royal College of Physicians: Nicotine Without Smoke: Tobacco Harm Reduction; Royal College of Physicians, London, UK, 2016. Available at https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction (accessed March 2022). Royal College of Physicians Nicotine Without Smoke: Tobacco Harm Reduction Royal College of Physicians London, UK 2016 Available at https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction (accessed March 2022). Search in Google Scholar

3 McNeill, A., L.S. Brose, R. Calder, L. Bauld, and D. Robson: Evidence Review of E-Cigarettes and Heated Tobacco Products 2018: A Report Commissioned by Public Health England; Public Health England, London, UK, 2018. Available at https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/684963/Evidence_review_of_e-cigarettes_and_heated_tobacco_products_2018.pdf (accessed February 2022). McNeillA. BroseL.S. CalderR. BauldL. RobsonD. Evidence Review of E-Cigarettes and Heated Tobacco Products 2018: A Report Commissioned by Public Health England Public Health England London, UK 2018 Available at https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/684963/Evidence_review_of_e-cigarettes_and_heated_tobacco_products_2018.pdf (accessed February 2022). Search in Google Scholar

4 The National Academies of Sciences, Engineering, Medicine: Consensus Study. Public Health Consequences of E-Cigarettes; National Academies Press, Washington, DC, USA, 2018. DOI: 10.17226/24952 The National Academies of Sciences, Engineering, Medicine Consensus Study Public Health Consequences of E-Cigarettes National Academies Press Washington, DC, USA 2018 10.17226/24952 29894118 Open DOISearch in Google Scholar

5 Takahashi, Y., Y. Kanemaru, T. Fukushima, K. Eguchi, S. Yoshida, J. Miller-Holt, and I. Jones: Chemical Analysis and In Vitro Toxicological Evaluation of Aerosol From a Novel Tobacco Vapor Product: A Comparison With Cigarette Smoke; Regul. Toxicol. Pharmacol. 92 (2018) 94–103. DOI: 10.1016/j.yrtph.2017.11.009 TakahashiY. KanemaruY. FukushimaT. EguchiK. YoshidaS. Miller-HoltJ. JonesI. Chemical Analysis and In Vitro Toxicological Evaluation of Aerosol From a Novel Tobacco Vapor Product: A Comparison With Cigarette Smoke Regul. Toxicol. Pharmacol. 2018 92 94 103 10.1016/j.yrtph.2017.11.009 29158044 Open DOISearch in Google Scholar

6 Eaton, D., B. Jakaj, M. Forster, J. Nicol, E. Mavropoulou, K. Scott, C. Liu, K. McAdam, J. Murphy, and C.J. Proctor: Assessment of Tobacco Heating Product THP1.0. Part 2: Product Design, Operation and Thermophysical Characterisation; Regul. Toxicol. Pharmacol. 93 (2018) 4–13. DOI: 10.1016/j.yrtph.2017.09.009 EatonD. JakajB. ForsterM. NicolJ. MavropoulouE. ScottK. LiuC. McAdamK. MurphyJ. ProctorC.J. Assessment of Tobacco Heating Product THP1.0. Part 2: Product Design, Operation and Thermophysical Characterisation Regul. Toxicol. Pharmacol. 2018 93 4 13 10.1016/j.yrtph.2017.09.009 29080851 Open DOISearch in Google Scholar

7 Schaller, J.-P., D. Keller, L. Poget, P. Pratte, E. Kaelin, D. McHugh, G. Cudazzo, D. Smart, A.R. Tricker, L. Gautier, M. Yerly, R. Reis Pires, S. Le Bouhellec, D. Ghosh, I. Hofer, E. Garcia, P. Vanscheeuwijck, and S. Maeder: Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical Composition, Genotoxicity, Cytotoxicity, and Physical Properties of the Aerosol; Regul. Toxicol. Pharmacol. 81 (2016) S27–S47. DOI: 10.1016/j.yrtph.2016.10.001 SchallerJ.-P. KellerD. PogetL. PratteP. KaelinE. McHughD. CudazzoG. SmartD. TrickerA.R. GautierL. YerlyM. Reis PiresR. Le BouhellecS. GhoshD. HoferI. GarciaE. VanscheeuwijckP. MaederS. Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical Composition, Genotoxicity, Cytotoxicity, and Physical Properties of the Aerosol Regul. Toxicol. Pharmacol. 2016 81 S27 S47 10.1016/j.yrtph.2016.10.001 27720919 Open DOISearch in Google Scholar

8 Smith, M.R., B. Clark, F. Lüdicke, J.P. Schaller, P. Vanscheeuwijck, J. Hoeng, and M.C. Peitsch: Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the System and the Scientific Assessment Program; Regul. Toxicol. Pharmacol. 81 (2016) S17–S26. DOI: 10.1016/j.yrtph.2016.07.006 SmithM.R. ClarkB. LüdickeF. SchallerJ.P. VanscheeuwijckP. HoengJ. PeitschM.C. Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the System and the Scientific Assessment Program Regul. Toxicol. Pharmacol. 2016 81 S17 S26 10.1016/j.yrtph.2016.07.006 27450400 Open DOISearch in Google Scholar

9 U.S. Food and Drug Administration (FDA): Modified Risk Orders. IQOS System Holder and Charger; FDA, Silver Spring, MD, USA, 2020. Available at https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-orders (accessed February 2022). U.S. Food and Drug Administration (FDA) Modified Risk Orders IQOS System Holder and Charger FDA Silver Spring, MD, USA 2020 Available at https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-orders (accessed February 2022). Search in Google Scholar

10 U.S. Food and Drug Administration (FDA): Guidance for Industry. Modified Risk Tobacco Product Applications. Draft Guidance; FDA, Silver Spring MD, USA, 2012. Available at https://www.fda.gov/media/83300/download (accessed February 2022). U.S. Food and Drug Administration (FDA) Guidance for Industry Modified Risk Tobacco Product Applications. Draft Guidance FDA Silver Spring MD, USA 2012 Available at https://www.fda.gov/media/83300/download (accessed February 2022). Search in Google Scholar

11 U.S. Food and Drug Administration (FDA): Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products. Guidance for Industry and Food and Drug Administration Staff; FDA, Silver Spring, MD, USA, 2011. Available at https://www.fda.gov/-regulatory-information/search-fda-guidance-documents/section-905j-reports-demonstrating-substantial-equivalence-tobacco-products (accessed February 2022) U.S. Food and Drug Administration (FDA) Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products. Guidance for Industry and Food and Drug Administration Staff FDA Silver Spring, MD, USA 2011 Available at https://www.fda.gov/-regulatory-information/search-fda-guidance-documents/section-905j-reports-demonstrating-substantial-equivalence-tobacco-products (accessed February 2022) Search in Google Scholar

12 Midha, K.K. and G. McKay: Bioequivalence: Its History, Practice, and Future; AAPS J. 11 (2009) 664–670. DOI 10.1208/s12248-009-9142-z MidhaK.K. McKayG. Bioequivalence: Its History, Practice, and Future AAPS J. 2009 11 664 670 10.1208/s12248-009-9142-z 278207619806461 Open DOISearch in Google Scholar

13 Schlage, W.K., B. Titz, A. Iskandar, C. Poussin, M. Van der Toorn, E.T. Wong, P. Pratte, S. Maeder, J.P. Schaller, P. Pospisil, S. Boué, G. Vuillaume, P. Leroy, F. Martin, N.V. Ivanov, M.C. Peitsch, and J. Hoeng: Comparing the Preclinical Risk Profile of Inhalable Candidate and Potential Candidate Modified Risk Tobacco Products: A Bridging Use Case; Toxicol. Rep. 7 (2020) 1187–1206. DOI: 10.1016/j.toxrep.2020.09.004 SchlageW.K. TitzB. IskandarA. PoussinC. Van der ToornM. WongE.T. PratteP. MaederS. SchallerJ.P. PospisilP. BouéS. VuillaumeG. LeroyP. MartinF. IvanovN.V. PeitschM.C. HoengJ. Comparing the Preclinical Risk Profile of Inhalable Candidate and Potential Candidate Modified Risk Tobacco Products: A Bridging Use Case Toxicol. Rep. 2020 7 1187 1206 10.1016/j.toxrep.2020.09.004 750237832995294 Open DOISearch in Google Scholar

14 Proctor, C.: Assessment of Tobacco Heating Product THP1.0. Part 1: Series Introduction; Regul. Toxicol. Pharmacol. 93 (2018) 1–3. DOI: 10.1016/j.yrtph.2017.09.010 ProctorC. Assessment of Tobacco Heating Product THP1.0. Part 1: Series Introduction Regul. Toxicol. Pharmacol. 2018 93 1 3 10.1016/j.yrtph.2017.09.010 28989081 Open DOISearch in Google Scholar

15 Jaunky, T., J. Adamson, S. Santopietro, A. Terry, D. Thorne, D. Breheny, C. Proctor, and M. Gaça: Assessment of Tobacco Heating Product THP1.0. Part 5: In Vitro Dosimetric and Cytotoxic Assessment; Regul. Toxicol. Pharmacol. 93 (2018) 52–61. DOI: 10.1016/j.yrtph.2017.09.016 JaunkyT. AdamsonJ. SantopietroS. TerryA. ThorneD. BrehenyD. ProctorC. GaçaM. Assessment of Tobacco Heating Product THP1.0. Part 5: In Vitro Dosimetric and Cytotoxic Assessment Regul. Toxicol. Pharmacol. 2018 93 52 61 10.1016/j.yrtph.2017.09.016 28987911 Open DOISearch in Google Scholar

16 Forster, M., S. Fiebelkorn, C. Yurteri, D. Mariner, C. Liu, C. Wright, K. McAdam, J. Murphy, and C. Proctor: Assessment of Novel Tobacco Heating Product THP1.0. Part 3: Comprehensive Chemical Characterisation of Harmful and Potentially Harmful Aerosol Emissions; Regul. Toxicol. Pharmacol. 93 (2018) 14–33. DOI: 10.1016/j.yrtph.2017.10.006 ForsterM. FiebelkornS. YurteriC. MarinerD. LiuC. WrightC. McAdamK. MurphyJ. ProctorC. Assessment of Novel Tobacco Heating Product THP1.0. Part 3: Comprehensive Chemical Characterisation of Harmful and Potentially Harmful Aerosol Emissions Regul. Toxicol. Pharmacol. 2018 93 14 33 10.1016/j.yrtph.2017.10.006 29080848 Open DOISearch in Google Scholar

17 Thorne, D., D. Breheny, C. Proctor, and M. Gaça: Assessment of Novel Tobacco Heating Product THP1.0. Part 7: Comparative In Vitro Toxicological Evaluation; Regul. Toxicol. Pharmacol. 93 (2018) 71–83. DOI: 10.1016/j.yrtph.2017.08.017 ThorneD. BrehenyD. ProctorC. GaçaM. Assessment of Novel Tobacco Heating Product THP1.0. Part 7: Comparative In Vitro Toxicological Evaluation Regul. Toxicol. Pharmacol. 2018 93 71 83 10.1016/j.yrtph.2017.08.017 29080850 Open DOISearch in Google Scholar

18 Taylor, M., D. Thorne, T. Carr, D. Breheny, P. Walker, C. Proctor, and M. Gaça: Assessment of Novel Tobacco Heating Product THP1.0. Part 6: A Comparative In Vitro Study Using Contemporary Screening Approaches; Regul. Toxicol. Pharmacol. 93 (2018) 62–70. DOI: 10.1016/j.yrtph.2017.08.016 TaylorM. ThorneD. CarrT. BrehenyD. WalkerP. ProctorC. GaçaM. Assessment of Novel Tobacco Heating Product THP1.0. Part 6: A Comparative In Vitro Study Using Contemporary Screening Approaches Regul. Toxicol. Pharmacol. 2018 93 62 70 10.1016/j.yrtph.2017.08.016 29080849 Open DOISearch in Google Scholar

19 Murphy, J., C. Liu, K. McAdam, M. Gaça, K. Prasad, O. Camacho, J. McAughey, and C. Proctor: Assessment of Tobacco Heating Product THP1.0. Part 9: The Placement of a Range of Next-Generation Products on an Emissions Continuum Relative to Cigarettes via Pre-Clinical Assessment Studies; Regul. Toxicol. Pharmacol. 93 (2018) 92–104. DOI: 10.1016/j.yrtph.2017.10.001 MurphyJ. LiuC. McAdamK. GaçaM. PrasadK. CamachoO. McAugheyJ. ProctorC. Assessment of Tobacco Heating Product THP1.0. Part 9: The Placement of a Range of Next-Generation Products on an Emissions Continuum Relative to Cigarettes via Pre-Clinical Assessment Studies Regul. Toxicol. Pharmacol. 2018 93 92 104 10.1016/j.yrtph.2017.10.001 29080852 Open DOISearch in Google Scholar

20 Gee, J., K. Prasad, S. Slayford, A. Gray, K. Nother, A. Cunningham, E. Mavropoulou, and C. Proctor: Assessment of Tobacco Heating Product THP1.0. Part 8: Study to Determine Puffing Topography, Mouth Level Exposure and Consumption Among Japanese Users; Regul. Toxicol. Pharmacol. 93 (2018) 84–91. DOI: 10.1016/j.yrtph.2017.08.005 GeeJ. PrasadK. SlayfordS. GrayA. NotherK. CunninghamA. MavropoulouE. ProctorC. Assessment of Tobacco Heating Product THP1.0. Part 8: Study to Determine Puffing Topography, Mouth Level Exposure and Consumption Among Japanese Users Regul. Toxicol. Pharmacol. 2018 93 84 91 10.1016/j.yrtph.2017.08.005 28822877 Open DOISearch in Google Scholar

21 21, Forster, M., J. McAughey, K. Prasad, E. Mavropoulou, and C. Proctor: Assessment of Tobacco Heating Product THP1.0. Part 4: Characterisation of Indoor Air Quality and Odour; Regul. Toxicol. Pharmacol. 93 (2018) 34–51. DOI: 10.1016/j.yrtph.2017.09.017 ForsterM. McAugheyJ. PrasadK MavropoulouE. ProctorC. Assessment of Tobacco Heating Product THP1.0. Part 4: Characterisation of Indoor Air Quality and Odour Regul. Toxicol. Pharmacol. 2018 93 34 51 10.1016/j.yrtph.2017.09.017 28989082 Open DOISearch in Google Scholar

22 Health Canada: Official Method T-115 – Determination of “Tar”, Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke; Health Canada, Ottawa, Canada, 1999. Health Canada Official Method T-115 – Determination of “Tar”, Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke Health Canada Ottawa, Canada 1999 Search in Google Scholar

23 World Health Organization (WHO): Report on the Scientific Basis of Tobacco Product Regulation – TRS 1015; Study Group on Tobacco Product Regulation, World Health Organization, Geneva, Switzerland, 2019. World Health Organization (WHO) Report on the Scientific Basis of Tobacco Product Regulation – TRS 1015; Study Group on Tobacco Product Regulation World Health Organization Geneva, Switzerland 2019 Search in Google Scholar

24 Adamson, J., T. Jaunky, D. Thorne, and M.D. Gaça: Characterisation of the Borgwaldt LM4E System for In Vitro Exposures to Undiluted Aerosols From Next Generation Tobacco and Nicotine Products (NGPs); Food Chem. Toxicol. 113 (2018) 337–344. DOI: 10.1016/j.fct.2018.02.005 AdamsonJ. JaunkyT. ThorneD. GaçaM.D. Characterisation of the Borgwaldt LM4E System for In Vitro Exposures to Undiluted Aerosols From Next Generation Tobacco and Nicotine Products (NGPs) Food Chem. Toxicol. 2018 113 337 344 10.1016/j.fct.2018.02.005 29421647 Open DOISearch in Google Scholar

25 Bishop, E., L. Haswell, J. Adamson, S. Costigan, D. Thorne, and M. Gaça: An Approach to Testing Undiluted E-Cigarette Aerosol In Vitro Using 3D Reconstituted Human Airway Epithelium; Toxicol. In Vitro 54 (2019) 391–401. DOI: 10.1016/j.tiv.2018.01.010 BishopE. HaswellL. AdamsonJ. CostiganS. ThorneD. GaçaM. An Approach to Testing Undiluted E-Cigarette Aerosol In Vitro Using 3D Reconstituted Human Airway Epithelium Toxicol. In Vitro 2019 54 391 401 10.1016/j.tiv.2018.01.010 29355593 Open DOISearch in Google Scholar

26 Azzopardi, D., L.E. Haswell, G. Foss-Smith, K. Hewitt, N. Asquith, S. Corke, and G. Phillips: Evaluation of an Air-Liquid Interface Cell Culture Model for Studies on the Inflammatory and Cytotoxic Responses to Tobacco Smoke Aerosols; Toxicol. In Vitro 29 (2015) 1720–1728. DOI: 10.1016/j.tiv.2015.06.016 AzzopardiD. HaswellL.E. Foss-SmithG. HewittK. AsquithN. CorkeS. PhillipsG. Evaluation of an Air-Liquid Interface Cell Culture Model for Studies on the Inflammatory and Cytotoxic Responses to Tobacco Smoke Aerosols Toxicol. In Vitro 2015 29 1720 1728 10.1016/j.tiv.2015.06.016 26096598 Open DOISearch in Google Scholar

27 Costigan, S. and C. Meredith: An Approach to Ingredient Screening and Toxicological Risk Assessment of Flavours in E-Liquids; Regul. Toxicol. Pharmacol. 72 (2015) 361–369. DOI: 10.1016/j.yrtph.2015.05.018 CostiganS. MeredithC. An Approach to Ingredient Screening and Toxicological Risk Assessment of Flavours in E-Liquids Regul. Toxicol. Pharmacol. 2015 72 361 369 10.1016/j.yrtph.2015.05.018 26026505 Open DOISearch in Google Scholar